{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-5197", "FDA", "Medical Devices; Neurological Devices; Classification of the Transcutaneous Electrical Nerve Stimulator to Treat Fibromyalgia Symptoms", "Rulemaking", "2026-05-29T13:44:55Z", "0b000064b92cfd82"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-5197"], "units": {}, "query_ms": 0.24817598750814795, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}